Colgate-Palmolive Company ($CL) Stock Forecast: Up 5.0% Today

What is Colgate-Palmolive Company?

Colgate-Palmolive (CL) is a multinational consumer goods company known for its oral care products, personal care products, and pet nutrition. The company operates globally and has a strong presence in various markets.

Why is Colgate-Palmolive Company going up?

CL stock is up 5.0% on Jan 30, 2026 19:55

• Colgate-Palmolive (CL) stock rose over 5% in a strong bullish movement recently.
• Investors reacted positively to the company's better-than-expected organic sales growth in the fourth quarter, particularly due to a successful rebound in Latin America.
• Despite facing a notable non-cash impairment charge linked to its skin health business, investors focused on the strength of the core business and sales growth, leading to an increase in the stock price.
• Colgate-Palmolive's cautious outlook for 2026 includes an expected organic sales growth ranging between 1% and 4%, an increase in advertising spending, and utilizing strong operating cash flow, all of which boosted investor confidence in the company's future prospects.

CL Price Chart

CL Technical Analysis

CL News

CL Earnings: Colgate-Palmolive Stock Skyrockets over 5% as Sales Growth Beats Estimates on LATAM Rebound

Colgate-Palmolive shares rose over 5% after reporting better-than-expected organic sales growth of 2.2% in the fourth quarter, largely due to a successful recovery in Latin America. Despite a significant non-cash impairment charge related to its skin health business, the company's core operations showed resilience. Looking ahead, Colgate-Palmolive provided a cautious 2026 outlook with expected organic sales growth between 1% and 4%, while planning increased advertising spend and leveraging its strong operating cash flow.

https://www.tipranks.com/news/auto-draft-6

Colgate-Palmolive 8-K Filing Analysis

Colgate-Palmolive has released its Q4 and full-year 2025 financial results, reporting slight net sales growth and a decline in GAAP EPS due to impairment charges related to its skin health business. Despite these challenges, the company posted record net cash from operations and returned significant funds to shareholders. CEO Noel Wallace highlighted the success of the 2025 strategy and introduced the new 2030 strategy focused on growth through innovation and data leverage.

https://www.tradingview.com/news/tradingview:76b7fa8e89a6d:0-colgate-palmolive-8-k-filing-analysis/

Colgate-Palmolive (CL) stock gains after Q4 FY25 sales and earnings top expectations

Colgate-Palmolive (CL) reported strong Q4 FY25 financial results, with both sales and adjusted earnings per share surpassing analyst expectations, leading to a premarket stock gain. The company's net sales rose to $5.23 billion, and adjusted earnings hit $0.95 per share. For fiscal 2026, Colgate-Palmolive forecasts net sales growth of 2% to 6% and double-digit earnings per share growth, despite anticipating a challenging operating environment.

https://news.alphastreet.com/colgate-palmolive-cl-stock-gains-after-q4-fy25-sales-and-earnings-top-expectations/

Colgate-Palmolive Co. (NYSE:CL) Navigates Mixed Q4 Results with Impairment Charge and Sales Beat

Colgate-Palmolive Co. (NYSE:CL) reported mixed Q4 results, with sales and adjusted earnings beating expectations, but GAAP EPS reflecting a significant $794 million non-cash impairment charge related to its skin health business. Despite the impairment, pre-market trading showed a positive reaction, indicating investors are focusing on the core business strength and sales growth. The company provided 2026 guidance, expecting net sales growth of 2% to 6% and low to mid-single-digit EPS growth on a non-GAAP basis.

https://www.chartmill.com/news/CL/Chartmill-40797-Colgate-Palmolive-Co-NYSECL-Navigates-Mixed-Q4-Results-with-Impairment-Charge-and-Sales-Beat

Colgate-Palmolive Swings to a Loss on Charges

Colgate-Palmolive reported a loss in the fourth quarter due to a significant charge related to its struggling skin-health business. Despite the loss, the company's sales increased to $5.23 billion, surpassing Wall Street expectations. This financial downturn contrasts with a profit of $739 million in the same period last year.

https://www.wsj.com/business/earnings/colgate-palmolive-swings-to-a-loss-on-charges-9c5715f2?gaa_at=eafs&gaa_n=AWEtsqfg-26PVppb15hcPIFraRPXjNuXp2iFfdeaXkwhrqtzdmv-wjJau_K7&gaa_ts=697cada0&gaa_sig=d8Vpmkk6_Rmqe10cE2NJyevjihBEhBZtU__VrBLc-6cZ19rSjiPbViuuoI8UQtASMBPPRxexZiGYbO8j0cWwnA%3D%3D

Trending Today

POL (Polygon) ($POL) Crypto Forecast: Up 8.8% Today

Silver ($XAG) Commodity Forecast: Down 8.3% Today

SolarEdge Technologies, Inc. ($SEDG) Stock Forecast: Down 5.1% Today

Iron Mountain Incorporated (Delaware)Common Stock REIT ($IRM) Stock Forecast: Up 5.2% Today

Marathon Petroleum Corporation ($MPC) Stock Forecast: Down 5.2% Today

Palantir Technologies Inc ($PLTR) Stock Forecast: Down 5.1% Today

Teladoc Health Inc. ($TDOC) Stock Forecast: Down 5.0% Today

Gartner Inc. ($IT) Stock Forecast: Down 5.1% Today

CBRE Group Inc Class A ($CBRE) Stock Forecast: Down 8.3% Today

Lincoln National Corporation ($LNC) Stock Forecast: Up 5.4% Today

Colgate-Palmolive Company Price History

31.00.2025 - CL Stock was down 5.2%

• Colgate-Palmolive outperformed earnings expectations in Q4; however, the stock saw a bearish movement, likely attributed to falling short of sales targets and providing a cautious outlook for FY25.
• Investors may have been disappointed by the company's forecast of flat sales growth for FY25, leading to a negative investor sentiment towards the stock.
• The discrepancy between surpassing earnings estimates and the less optimistic future projections could have prompted investors to reassess the stock's growth potential, influencing the overall market response.

26.03.2024 - CL Stock was up 1.1%

• CL stock experienced a strong bullish movement today.
• The company surpassed analyst revenue forecasts and delivered robust first-quarter results.
• Colgate-Palmolive's strong performance and raised revenue growth outlook likely contributed to the bullish market movement.
• Amidst geopolitical uncertainties and sticky inflation, investors may be seeking stability in reliable stocks like Colgate-Palmolive, further boosting the stock's bullish momentum.

30.09.2023 - CL Stock was up 2.6%

• Colgate-Palmolive reported strong Q3 results and raised its guidance, indicating solid demand for its products.
• The stock's bullish movement could be attributed to the company's positive earnings report and surpassing Q3 earnings estimates.
• The overall market sentiment, with the Sensex gaining points and the Nifty reaching new highs, could have also contributed to the bullish movement.
• It's worth noting that the article mentioning the Middle East situation and market fear does not seem directly related to Colgate-Palmolive's specific market movement.

28.05.2023 - CL Stock was down 1.8%

• The bearish movement in CL stock could be attributed to the negative sentiment caused by the news articles highlighting the high price of Colgate toothpaste at Tesco.
• The outrage expressed by Tesco shoppers and the negative publicity surrounding the pricing could have led investors to sell off their CL shares, resulting in the bearish movement.
• The article mentioning the surge in implied volatility for CL stock options indicates that investors may have been concerned about the potential impact of the negative news on the company's future performance.
• Despite the overall bearish movement, it is worth noting that there was a small gain in CL shares as the Sensex (stock market index) rose, suggesting some resilience in the face of the negative news.

21.10.2025 - CL Stock was up 3.1%

• Despite a slight decline in the current session, Colgate-Palmolive (CL) demonstrated a strong bullish movement overall.
• The recent stock price decrease over the past month and year could have attracted long-term shareholders seeking a potential buying opportunity.
• There is growing investor optimism regarding the company's future performance and growth prospects, which has resulted in increased buying pressure and pushed the stock price higher.
• Overall, market sentiment towards Colgate-Palmolive appears positive, potentially driven by expectations of improved financial results or strategic developments within the company.

22.09.2025 - CL Stock was up 2.0%

• The bullish movement in CL could be attributed to investors favoring the stock as a better value option compared to its competitor GO.
• This comparison might have led to increased interest and buying activity in CL, driving its stock price higher.
• Investors may have perceived CL as a more attractive investment opportunity based on various valuation metrics and growth prospects.

01.07.2025 - CL Stock was down 2.0%

• The bearish movement in CL stock today could be due to investors' concerns about the company's performance in the upcoming earnings report.
• The market may have reacted negatively to any signs of weakness or missed estimates beyond just revenue and EPS.
• Investors might be adjusting their positions based on a more cautious outlook for Colgate-Palmolive, leading to downward pressure on the stock price.

30.00.2026 - CL Stock was up 5.1%

• Colgate-Palmolive faced a loss in the fourth quarter due to charges stemming from its skin-health business. However, the company exceeded sales expectations, primarily driven by the continuous high demand for oral care and cleaning products.
• The company's positive outlook on annual sales, fueled by strong consumer demand for essential items, played a role in the stock's optimistic trajectory.
• Colgate-Palmolive's success in enhancing margins through price adjustments and the favorable performance of its international sales bolstered investor confidence in its future outlook.
• Analysts foresee similar growth rates in revenue for the coming 12 months, hinting at potential challenges in sustaining demand, a factor that investors will monitor closely.

30.00.2026 - CL Stock was up 5.0%

• Colgate-Palmolive (CL) stock rose over 5% in a strong bullish movement recently.
• Investors reacted positively to the company's better-than-expected organic sales growth in the fourth quarter, particularly due to a successful rebound in Latin America.
• Despite facing a notable non-cash impairment charge linked to its skin health business, investors focused on the strength of the core business and sales growth, leading to an increase in the stock price.
• Colgate-Palmolive's cautious outlook for 2026 includes an expected organic sales growth ranging between 1% and 4%, an increase in advertising spending, and utilizing strong operating cash flow, all of which boosted investor confidence in the company's future prospects.

08.00.2026 - CL Stock was up 5.0%

• CL showed strong bullish movement recently.
• Increased investor interest in CL was influenced by factors like stable product demand, cost reductions, enhanced marketing strategies, and an attractive dividend profile.
• Analysts foresee future growth in revenue and profitability for CL, fostering positive investor sentiment.
• An upgrade by Piper Sandler to "Overweight" and a rise in the price target added to the upbeat outlook on Colgate-Palmolive's future performance.